Clinical Decision Support & Reference tools for Hematology

7 clinical decision support & reference tools built for Hematology physicians.

Elsevier

Clinical Decision Support & Reference

ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.

Paid subscription, with individual and institutional plans.

Mendel.ai

Clinical Decision Support & Reference

Mendel.ai uses Neuro-Symbolic AI to sort patient cohorts from EHRs for clinical trial matching, accelerating research.

Contact for pricing

GenomOncology Precision Oncology

GenomOncology

Clinical Decision Support & Reference

GenomOncology's Precision Oncology Platform (POP) provides a comprehensive suite of end-to-end clinical informatics solutions for cancer, built upon an augmented intelligence stack that houses extensive rules, annotations, and ontologies. This enables users to move, convert, and interpret complex genomic and clinical data sets, transforming genomic data into actionable information.

CancerLinQ SmartLinQ (RxLinQ & TriaLinQ)

ConcertAI (an ASCO initiative)

Clinical Decision Support & Reference

CancerLinQ SmartLinQ (RxLinQ & TriaLinQ) is a precision oncology platform by ConcertAI that uses AI and real-world data to identify patients for new therapies and clinical trials, streamlining oncology workflows.

Contact for pricing

ASCO Guidelines Assistant

American Society of Clinical Oncology (ASCO) / Google Cloud

Clinical Decision Support & Reference

The ASCO Guidelines Assistant is an AI tool, developed by ASCO and Google Cloud, that helps oncologists quickly access evidence-based clinical guidelines, providing timely and trustworthy information to support patient care decisions.

Paid membership

Flatiron Health OncologyCloud

Flatiron Health

Clinical Decision Support & Reference

Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer.

Not publicly available for the full oncologycloud suite; api pricing details are available.

23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia

23andMe

Clinical Decision Support & Reference

The 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia is an FDA-cleared direct-to-consumer genetic test that identifies specific genetic variants (Factor V Leiden and Prothrombin G20210A) associated with an increased risk of developing harmful blood clots. It provides personal genetic insights for proactive health discussions with healthcare professionals.

$199

More for Hematology:

Lab & Diagnostics (22) Pathology AI (18) Oncology AI (15) Drug Discovery & Research (13) Radiology & Imaging AI (2) Pharmacology & Dosing AI (2) Patient Engagement & Education (1) Medical Education & Training (1) Gastroenterology AI (1) Developer Tools & APIs (1) General Productivity (AI Assistants) (1) Practice Analytics & BI (1)